CING
NASDAQ · Pharmaceuticals
Cingulate Inc
$7.38
-0.13 (-1.73%)
Analyst Consensus
Strong Buy
9
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+94.9% upside
Low Target
$9.95
Average Target
$14.38
High Target
$17.66
Current Price
$7.38
Current
$7.38
$7.38
Target
$14.38
$14.38
$9.95
$14.38 avg
$17.66
Scenario Analysis
Bear Case
$9.95
34.8%
Low target
Base Case
$14.38
+94.9%
Avg target
Bull Case
$17.66
+139.3%
High target
Risk/Reward
4.0x
Highly favorable
Price in Context
52-Week High
$11.89
-37.9% from high
52-Week Low
$3.20
+130.6% from low
Target vs 52W High
$14.38
+20.9% vs high
Peer Consensus — Pharmaceuticals
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| LLY | Strong Buy | 39 | 77% | $1,330.33 | +45.2% |
| JNJ | Buy | 32 | 59% | $299.55 | +24.8% |
| MRK | Buy | 36 | 67% | $159.27 | +33.4% |
| PFE | Hold | 35 | 40% | $33.90 | +24.3% |
| BMY | Hold | 36 | 42% | $174.50 | +196.1% |
| ZTS | Buy | 25 | 64% | $209.87 | +79.8% |
| RPRX | Strong Buy | 16 | 88% | $36.26 | -22.9% |
| VTRS | Buy | 18 | 67% | $122.82 | +809.8% |